Today: 5 April 2026
KLA stock price tumbles 15% after earnings — what traders watch next for KLAC
2 February 2026
1 min read

KLA stock price tumbles 15% after earnings — what traders watch next for KLAC

New York, Feb 1, 2026, 18:17 ET — The market has closed.

  • KLA shares ended Friday at $1,427.94, slipping roughly 15%.
  • The decline came after the company’s quarterly update, as investors dug into its outlook on chip-tool demand.
  • Attention turns to Monday’s open and crucial U.S. data scheduled for later this week.

KLA shares dropped 15.2% on Friday, closing at $1,427.94. Investors dumped the chipmaking equipment maker after its recent forecast fell short of expectations following a strong pre-earnings rally. Investing.com

Markets are closed for the weekend, putting the spotlight on the stock ahead of Monday’s session. Traders will watch closely to see if the selloff was just a one-day dip or the beginning of a deeper slide.

KLA holds a key role as a top supplier of inspection and metrology equipment — the “process control” gear that helps chipmakers detect defects and boost yields. Its forecasts frequently influence projections for wafer fab equipment (WFE) spending, the crucial chip factory tool budget.

KLA exceeded Wall Street expectations for both quarterly revenue and adjusted earnings, and its guidance for the March quarter came in broadly ahead of estimates. Yet, shares dropped roughly 7% in after-hours trading. Michael Ashley Schulman, CIO at Running Point Capital Advisors, noted the stock had “already sprinted into the print” and described the March-quarter outlook as “steady growth rather than renewed acceleration.” Reuters

CEO Rick Wallace called it a “record quarter” in the earnings release, highlighting strong process control demand from top-tier foundry, logic, and memory sectors. He also noted KLA is benefiting from the surge in AI infrastructure investment. KLA Corporation

Analysts wasted no time debating how much upside remains after KLA’s recent surge — and whether the company’s cautious take on WFE spending signals caution or a red flag. Needham’s Charles Shi said it’s “too early to call a race,” while UBS’s Timothy Arcuri trimmed his price target and held a neutral rating. J.P. Morgan’s Harlan Sur, meanwhile, pushed his target higher and stayed bullish. Barron’s

Peers have shifted the benchmark. Lam Research, for instance, recently predicted revenue that beat estimates. CEO Tim Archer commented, “Entering 2026, our expanding product and services portfolio is enabling the market’s transition” toward more complex devices and packages. Reuters

Downside risks are spelled out in KLA’s latest quarterly filing. The company pointed to changing export regulations that could limit sales and service to some Chinese clients, alongside tariffs and fluctuations in customer capital expenditures. KLA Corporation

On Monday, investors will watch closely for signals from chip-tool peers and major chip buyers. They’ll also be gauging if bargain hunters step in after the stock tumbled well below last week’s peaks.

Upcoming key events include Monday’s release of the Institute for Supply Management’s U.S. manufacturing PMI at 10:00 a.m. ET. Then on Friday, the U.S. Bureau of Labor Statistics will publish the Employment Situation report at 8:30 a.m. ET. Institute for Supply Management

Stock Market Today

  • Telix Pharmaceuticals Names David Gill to Board, Signals Governance Shift Amid Growth Focus
    April 5, 2026, 5:29 PM EDT. Telix Pharmaceuticals (ASX:TLX) appointed David Gill as a Non-Executive Director, set to succeed Dr. Mark Nelson as Chair in May 2026. Gill brings deep radiopharmaceutical and governance expertise, potentially reshaping Telix's strategy balancing growth and oversight. The company's core growth hinges on regulatory and commercial progress of pipeline assets like Pixclara and TLX591-Tx, with heavy R&D and manufacturing investment pressuring near-term earnings. The recent resubmission of TLX101-Px (Pixclara) for FDA approval is a key catalyst. Analysts' forecasts vary widely, with consensus projecting A$1.2 billion revenue and A$111.3 million earnings by 2029, but some cautioning on execution risks. The board change may influence how Telix navigates its development pipeline and investor expectations in the years ahead.
MediaTek stock heads into Monday with Feb. 4 results call in focus after Friday dip
Previous Story

MediaTek stock heads into Monday with Feb. 4 results call in focus after Friday dip

Qualcomm stock price slips into earnings week — what QCOM investors are watching next
Next Story

Qualcomm stock price slips into earnings week — what QCOM investors are watching next

Go toTop